comprehensive -WSS

comprehensive

author：knowledge 2025-09-28 08:53:46 - browse：6776

Eli Lilly said Friday it will acquire Versanis Bio, a private company developing an obesity drug that specifically targets fat mass, as the race among pharmaceutical companies to offer weight loss medications intensifies.

The deal indicates Lilly is aiming to diversify its growing portfolio of weight loss therapies, as Versanis’ drug employs an entirely different mechanism than the existing obesity drugs that Lilly is studying. The pharma giant didn’t say how much it would pay Versanis upfront, but said that if the drug meets certain milestones, the total payment could reach $1.9 billion.

Lilly, along with other pharma companies like Novo Nordisk, has been developing products in the class of GLP-1 drugs, which mimic the glucagon-like peptide 1 hormone that helps people feel full. These drugs – including Novo’s Ozempic and Wegovy, and Lilly’s Mounjaro – have exploded in popularity because they lead to significant weight loss.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Study on Amgen’s bispecific immunotherapy produces positive data

Wikipedia

WSS

STAT Summit: Ending the crisis of Black deaths in the U.S.

Readout LOUD podcast: Live from the 2023 STAT Summit

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Is there really a nursing shortage in the U.S.?

Ebola vaccine can save some who are already sick, per new study

explore

comprehensive

leisure time

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Congress considering partial increase for doctor pay in Medicare

United colonoscopy coverage change 'may cost lives,' doctors say

Artificial intelligence use in health care faces greater scrutiny in 2024

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

J&J lung cancer data amount to new salvo against AstraZeneca

Activists slam private health insurers over coverage restrictions

Too many hospitalized Covid

Malaria cases in Florida and Texas: Here’s what you need to know

Too many hospitalized Covid

hotspot

Study gives hint on South Asians’ higher risk of cardiovascular disease

Cassava Sciences’ Alzheimer’s clinical trials should be halted

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

Why don't Americans have at

Results on Novartis prostate cancer therapy could expand its use

Why a market frenzy over new weight loss drugs defies logic

Wikipedia

hotspot

Wikipedia

leisure time